Metabolic issues and cardiovascular disease in patients with psychiatric disorders

2005 ◽  
Vol 118 ◽  
pp. 15-22 ◽  
Author(s):  
Daniel E. Casey
2017 ◽  
Vol 52 (7) ◽  
pp. 837-846
Author(s):  
Leopoldo J. Cabassa ◽  
Roberto Lewis-Fernández ◽  
Shuai Wang ◽  
Carlos Blanco

2020 ◽  
Vol 21 (22) ◽  
pp. 8427
Author(s):  
Yu Ri Woo ◽  
Yu Jin Han ◽  
Hei Sung Kim ◽  
Sang Hyun Cho ◽  
Jeong Deuk Lee

Rosacea is a common chronic cutaneous inflammatory disorder. Recently, patients with rosacea were identified as having a higher risk of developing various comorbidities such as cardiovascular disease, psychiatric disorders, neurologic disorders, and gastrointestinal disorders. However, the risks of some comorbidities in patients with rosacea are somewhat contradictory, depending upon the study design. Moreover, pathomechanisms associated with the comorbidities of patients with rosacea remain poorly elucidated. The purpose of this review was to provide the most up-to-date evidence on the risks of neuropsychiatric and gastrointestinal comorbidities in patients with rosacea. Moreover, the molecular pathomechanisms associated with neuropsychiatric and gastrointestinal comorbidities in patients with rosacea were evaluated based on recent studies. This review was also intended to focus more on the role of the gut–brain–skin axis in the association of neuropsychiatric and gastrointestinal comorbidities in rosacea.


2019 ◽  
Author(s):  
Chenlu Li ◽  
Delia A. Gheorghe ◽  
John E.J. Gallacher ◽  
Sarah Bauermeister

AbstractBackgroundConceptualising comorbidity is complex and the term is used variously. Here, it is the coexistence of two or more diagnoses which might be defined as ‘chronic’ and, although they may be pathologically related, they may also act independently1. Of interest here is the comorbidity of common psychiatric disorders and impaired cognition.ObjectivesTo examine whether anxiety and/or depression are important longitudinal predictors of cognitive change.MethodsUK Biobank participants used at three time points (n= 502,664): baseline, 1st follow-up (n= 20,257) and 1st imaging study (n=40,199). Participants with no missing data were 1,175 participants aged 40 to 70 years, 41% female. Machine learning (ML) was applied and the main outcome measure of reaction time intraindividual variability (cognition) was used.FindingsUsing the area under the Receiver Operating Characteristic (ROC) curve, the anxiety model achieves the best performance with an Area Under the Curve (AUC) of 0.68, followed by the depression model with an AUC of 0.63. The cardiovascular and diabetes model, and the covariates model have weaker performance in predicting cognition, with an AUC of 0.60 and 0.56, respectively.ConclusionsOutcomes suggest psychiatric disorders are more important comorbidities of long-term cognitive change than diabetes and cardiovascular disease, and demographic factors. Findings suggest that psychiatric disorders (anxiety and depression) may have a deleterious effect on long-term cognition and should be considered as an important comorbid disorder of cognitive decline.Clinical implicationsImportant predictive effects of poor mental health on longitudinal cognitive decline should be considered in secondary and also primary care.Summary BoxWhat is already known about this subject? 3-4 bullet pointsPoor mental health is associated with cognitive deficits.One in four older adults experience a decline in affective state with increasing age.ML approaches have certain advantages in identifying patterns of information useful for the prediction of an outcome.What are the new findings? 3-4 bullet pointsPsychiatric disorders are important comorbid disorders of long-term cognitive change.Machine-learning methods such as sequence learning based methods are able to offer non-parametric joint modelling, allow for multiplicity of factors and provide prediction models that are more robust and accurate for longitudinal dataThe outcome of the RNN analysis found that anxiety and depression were stronger predictors of change IIV over time than either cardiovascular disease and diabetes or the covariate variables.How might it impact on clinical practice in the foreseeable future?The important predictive effect of mental health on longitudinal cognition should be noted and, its comorbidity relationship with other conditions such as cardiovascular disease likewise to be considered in primary care and other clinical settings


2009 ◽  
Vol 2009 ◽  
pp. 1-8 ◽  
Author(s):  
Britta A. Larsen ◽  
Nicholas J. S. Christenfeld

The high comorbidity between psychiatric disorders and cardiovascular disease has received increasing attention, yet little is known about the processes linking the two. One plausible contributing mechanism is the tendency of those with psychiatric disorders to ruminate on stressful events. This phenomenon, sometimes called perseverative cognition, can extend the psychological and physiological effects of stress, which could contribute to cardiovascular disease etiology. In this paper, we discuss the potential role of perseverative cognition in mediating the relationship between psychiatric illness and cardiovascular disease. Rumination can delay physiological recovery from acute stress, which in turn has been found to predict future cardiovascular health. This delayed recovery could act as a mechanism in the longitudinal link between worry and cardiovascular health. The cognitive inflexibility that characterizes mood and anxiety disorders may then contribute to disease not by producing greater reactivity, but instead through extending activation, increasing the risks for cardiovascular damage.


2020 ◽  
Author(s):  
Qing Shen ◽  
Yuanjun Ma ◽  
Anna Jöud ◽  
Maria E C Schelin ◽  
Katja Fall ◽  
...  

Abstract Background It is unknown whether the rate of psychiatric disorders and cardiovascular disease is increased during the diagnostic workup of suspected prostate cancer. Methods We designed a population-based cohort study including 579,992 men living during 2005–2014 in Skåne Sweden according to the Swedish Total Population Register and the Skåne Healthcare Register (SHR). We used the Swedish Cancer Register and the SHR to identify all men with a new diagnosis of prostate cancer (N = 10,996) and all men underwent a prostate biopsy without receiving a cancer diagnosis (biopsy group; N = 20,482) as exposed to a diagnostic workup. Using Poisson regression, we compared the rates of psychiatric disorders and cardiovascular disease during the period before diagnosis or biopsy of exposed men with the corresponding rates of unexposed men. Results We found an increased rate of psychiatric disorders during the period before diagnosis or biopsy among men with prostate cancer (incidence rate ratio [IRR]=1.87; 95% confidence interval [CI]=1.67 to 2.10) and men in biopsy group (IRR = 2.22; 95% CI = 2.08 to 2.37). The rate of cardiovascular disease was increased during the period before diagnosis or biopsy among men with prostate cancer (IRR = 2.22; 95% CI = 2.12 to 2.32) and men in biopsy group (IRR = 2.56; 95% CI = 2.49 to 2.63). Greater rate increases were noted for a diagnostic workup due to symptoms than due to other reasons. Conclusions There was an increased risk of psychiatric disorders and cardiovascular disease during the diagnostic workup of suspected prostate cancer, regardless of the final cancer diagnosis.


2019 ◽  
Vol 42 ◽  
Author(s):  
Hanna M. van Loo ◽  
Jan-Willem Romeijn

AbstractNetwork models block reductionism about psychiatric disorders only if models are interpreted in a realist manner – that is, taken to represent “what psychiatric disorders really are.” A flexible and more instrumentalist view of models is needed to improve our understanding of the heterogeneity and multifactorial character of psychiatric disorders.


Sign in / Sign up

Export Citation Format

Share Document